Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens. (Q52724209)
Jump to navigation
Jump to search
scientific article published in August 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens. |
scientific article published in August 2011 |
Statements
Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens. (English)
Klaus Hellmann
Josef Heine
Gabriele Braun
Radmila Paran-Dobesova
Vlasta Svobodova
1 August 2011
109 Suppl 1
S77-86
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference